Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Jorge Rodrigues

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The British Journal of Ophthalmology|October 31, 2013
Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanomaNathalie Cassoux, Manuel Jorge Rodrigues, Corine Plancher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Trastuzumab treatment in t1ab, node-negative, human epidermal growth factor receptor 2-overexpressing breast carcinomasManuel Jorge Rodrigues, Johanna Wassermann, Laurence Albiges, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The British Journal of Ophthalmology|October 31, 2013
Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanomaNathalie Cassoux, Manuel Jorge Rodrigues, Corine Plancher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Trastuzumab treatment in t1ab, node-negative, human epidermal growth factor receptor 2-overexpressing breast carcinomasManuel Jorge Rodrigues, Johanna Wassermann, Laurence Albiges, et al.
Pageof 2